VOR BIOPHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.74 USD | +3.57% |
|
-5.95% | -22.67% |
| 13/05 | Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating | MT |
| 09/05 | Vor Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VOR BIOPHARMA INC. | Other Biotechnology & Medical Research | +3.57% | -5.95% | -22.67% | -60.63% | - | 119M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- VOR Stock
- Charts Vor Biopharma Inc.
- Comparison Chart
